Urine Protein & Albumin Ratio Calculator

KDIGO Standardisation, Unit Conversion & Renal Risk Stratification · v1.1
How to use this tool: Enter the urine result in whatever units your laboratory reports. First-morning spot urine is preferred. The tool converts to the KDIGO standard units of mg/g and mg/mmol.

1. Select Target Analysis

2. Laboratory Parameters

Evidence & Clinical Pearls

The Concentration Caution in Indian Diagnostics:
Many local laboratories report raw "Spot Urine Microalbumin" levels (e.g., 25 mg/L) and flag them as abnormal if they exceed a generic cut-off (usually > 20 mg/L). This is physiologically misleading. A concentrated morning sample will naturally have higher raw solute concentrations. Always divide the raw albumin by urine creatinine (UACR) to normalise for urinary dilution.

1. KDIGO 2024 Albuminuria Categories (UACR)

Category UACR (mg/g) Clinical Interpretation
A1 < 30 Normal to mildly increased. Minimal risk if eGFR is preserved.
A2 30 – 300 Moderately increased (formerly microalbuminuria). Indicates early endothelial dysfunction or early Diabetic Kidney Disease.
A3 > 300 Severely increased (formerly macroalbuminuria). High risk for progression to ESRD and cardiovascular events.

2. Total Proteinuria Categories (UPCR)

While UACR is more sensitive for early diabetic or hypertensive changes, UPCR is essential for evaluating broader glomerular diseases where non-albumin proteins (e.g., globulins, light chains) are excreted.

  • Normal: < 150 mg/g (< 0.15 mg/mg)
  • Mild / Sub-nephrotic: 150 to 500 mg/g
  • Moderate / Overt: 500 to 3500 mg/g
  • Nephrotic Range: > 3500 mg/g (> 3.5 mg/mg). Requires prompt nephrology referral for probable biopsy.

3. Illness Scripts: Top 3 Aetiologies

Diagnosis Typical Ratio Profile Key Clinical Features
Diabetic Kidney Disease (DKD) Predominant UACR elevation initially (A2 → A3). Bland urinary sediment. Retinopathy often co-exists. Gradual progression.
Glomerulonephritis (e.g., IgA) High UPCR. Often nephrotic range. Active sediment (dysmorphic RBCs, RBC casts). Acute onset or post-infectious.
Hypertensive Nephrosclerosis Mild UACR/UPCR elevation (< 1000 mg/g). Long-standing HTN, LVH on ECG, small/contracted kidneys on ultrasound.
Therapeutic Implications: The presence of A2 or A3 albuminuria provides a compelling indication to initiate nephroprotective agents independent of glycaemic control. First-line agents include ACE inhibitors or ARBs (titrated to maximum tolerated dose) and SGLT2 inhibitors (e.g., Dapagliflozin, Empagliflozin). Non-steroidal MRAs (Finerenone) are indicated for residual albuminuria in Type 2 DM.
Abbreviations: ACE (Angiotensin-Converting Enzyme) · ACEi (Angiotensin-Converting Enzyme Inhibitor) · ARB (Angiotensin Receptor Blocker) · BP (Blood Pressure) · DKD (Diabetic Kidney Disease) · DM (Diabetes Mellitus) · ECG (Electrocardiogram) · eGFR (Estimated Glomerular Filtration Rate) · ESRD (End-Stage Renal Disease) · HTN (Hypertension) · IgA (Immunoglobulin A) · KDIGO (Kidney Disease: Improving Global Outcomes) · LVH (Left Ventricular Hypertrophy) · MRA (Mineralocorticoid Receptor Antagonist) · RAAS (Renin-Angiotensin-Aldosterone System) · RBC (Red Blood Cell) · SBAR (Situation, Background, Assessment, Recommendation) · SGLT2 (Sodium-Glucose Cotransporter-2) · SGLT2i (Sodium-Glucose Cotransporter-2 Inhibitor) · UACR (Urine Albumin-to-Creatinine Ratio) · UPCR (Urine Protein-to-Creatinine Ratio) · UTI (Urinary Tract Infection)
Algorithm References & Evidence Base
  1. Kidney Disease: Improving Global Outcomes (KDIGO) 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024;105(4S):S117-S314.
  2. Association of Physicians of India (API). API Guidelines on Management of Chronic Kidney Disease. In: API Medicine Update. 2023.
  3. Levey AS, Becker C, Inker LA. Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults. JAMA. 2015;313(8):837-846.
How to Cite This Tool

AMA Style:
Umakanth S. Urine Protein & Albumin Ratio Calculator. MEDiscuss. Published 2026. Accessed .

Vancouver Style:
Umakanth S. Urine Protein & Albumin Ratio Calculator [Internet]. MEDiscuss.org; 2026 [cited ]. Available from:

Disclaimer and scope
Disclaimer: This decision-support system is intended for healthcare professionals. It does not substitute clinical judgment. These algorithms are evidence-based, but medical knowledge evolves continuously. The treating physician retains absolute responsibility for all diagnostic, dosing, and therapeutic decisions. Always verify outputs against current institutional protocols and individual patient contexts.
© 2026 MEDiscuss.org. All rights reserved. This CDSS Module was designed and developed by Dr. Shashikiran Umakanth using the available evidence base. Provided free of charge for clinical use. Unauthorised reproduction or redistribution is strictly prohibited.
Category Foundational CalculatorsCalculator
Specialties Nephrology
Written and maintained by Dr Shashikiran Umakanth.
Last revised: 29 July 2026
Related Clinical Tools
AKI & CKD Staging PathwayOutpatient Diabetes PathwayCVD Risk & CKM Staging
Back to All Medical Calculators & Pathways